Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Human Chorionic Gonadotropin Market Today And What Is Its Future Size?

The size of the human chorionic gonadotropin market has seen consistent growth over recent years. The projections indicate a growth from $0.95 billion in 2024 to $1.02 billion in 2025, indicating an 8.4% compound annual growth rate (CAGR). The robust growth during the historical period is attributed to factors such as increased prevalence of hypogonadism among the elderly, enhanced understanding of HCG among healthcare professionals and patients, the growing trend of fertility tourism, a rise in the elderly population, and improved affordability and advancements in healthcare facilities.

The market size of human chorionic gonadotropin is predicted to witness substantial growth in the upcoming years, escalating to $1.41 billion by 2029 at a compound annual growth rate of 8.2%. The expansion during the forecast period is due to the rising cases of infertility, increasing occurrence of polycystic ovary syndrome, growing female infertility, and enhanced use of HCG in veterinary medicine. Notable trends during the predicted period encompass progress in pregnancy detection procedures, inventive drug formulation, integration of technology, emphasis on research and development, and innovation in products.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18638&type=smp

Which Key Factors Are Fueling Growth In The Human Chorionic Gonadotropin Market?

The escalating incidence of infertility is anticipated to propel the expansion of the human chorionic gonadotropin market. Infertility, defined as the incapacity to get pregnant after a year of regular, unprotected sex, is on the rise. This increase is due to a growing number of individuals and couples struggling to conceive, affected by various factors including late childbearing, lifestyle shifts, environmental hazards, and health conditions. Human chorionic gonadotropin (hCG) is utilized in infertility therapy to prompt ovulation in females and boost testosterone production in males, thereby enhancing the release of eggs and upgrading fertility results. For example, in April 2023, the World Health Organization, a Switzerland-based international organization, reported that infertility impacted approximately 17.5% of the global adult population, equating to roughly one out of every six individuals around the globe. This emphasizes the urgent requirement to augment access to affordable and high-quality fertility services for those in need. Consequently, the rising incidence of infertility is facilitating the expansion of the human chorionic gonadotropin market.

How Is The Human Chorionic Gonadotropin Market Segmented Across Key Categories?

The human chorionic gonadotropinmarket covered in this report is segmented –

1) By Technology: Natural Source Extraction; Recombinant Technology

2) By Therapeutic Area: Female Infertility Treatment; Oligospermic Treatment; Male Hypogonadism; Other Therapeutic Areas

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

4) By End User: Fertility Clinics; Research Institutions; Other End Users

Subsegments:

1) By Natural Source Extraction: Extraction From Pregnant Women’s Urine; Extraction From Animal Sources

2) By Recombinant Technology: Recombinant Hcg; Recombinant Hcg For Therapeutic Use; Recombinant Hcg For Diagnostic Applications

What Key Trends Are Driving Growth In The Human Chorionic Gonadotropin Market?

Prominent firms in the human chorionic gonadotropin market are concentrating on creating novel products like pregnancy detection kits. These kits aim to enhance diagnostic precision, better patient results, and broaden the companies’ market presence. The kits work by verifying the existence of human chorionic gonadotropin (hCG) in the body, thereby confirming pregnancy. For example, in June 2022, Proov, an established U.S.-based medical equipment manufacturing firm, introduced fresh hCG exams tailored explicitly for early pregnancy confirmation. These exams allow women to verify pregnancy up to six days earlier than their expected menstruation by detecting the presence of human chorionic gonadotropin (hCG) in their urine. They offer a high accuracy level, exceeding a reliability rate of 99. This pioneering product aims to grant women a reliable and convenient way to check their pregnancy status earlier than conventional exams, empowering them to make well-informed choices concerning their reproductive health.

Who Are The Leading Companies Driving The Human Chorionic Gonadotropin Market?

Major companies operating in the human chorionic gonadotropin market are Pfizer Inc., Merck & Co Inc., Novartis AG, Bristol-Myers Squibb Company, Fresenius Kabi AG, Janssen Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Limited, Menarini Group, Cipla Limited, Hikma Pharmaceuticals plc, Ferring Pharmaceuticals Inc., Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Lupin Limited, Shenzhen Hepalink Pharmaceutical Group Co. Ltd., Scripps Laboratories Inc., Aspen Pharmacare Holdings Limited, Corona Remedies Pvt Ltd., Sanzyme Private Limited, Biocare Medical LLC, Lee BioSolutions Inc., MyBioSource Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/human-chorionic-gonadotropin-global-market-report

Which Region Dominates The Human Chorionic Gonadotropin Market Today?

North America was the largest region in the human chorionic gonadotropin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=18638&type=smp

Browse Through More Reports Similar to the Global Human Chorionic Gonadotropin Market 2025, By The Business Research Company

Mineral And Bone Disorder Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/mineral-and-bone-disorder-treatment-global-market-report

Acute Spinal Cord Injury Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/acute-spinal-cord-injury-global-market-report

Cleanroom Technology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cleanroom-technology-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model